Drug intelligence / Profile preview

indapamide + losartan

Development stage
Phase 3
Lead developer
Servier
Modality
Small Molecules
Administration
Oral
01

Overview

Indapamide + losartan is a fixed-dose combination of two antihypertensive agents used to treat high blood pressure. Indapamide is a thiazide-like diuretic that acts on the distal convoluted tubule in the nephron, inhibiting the Na+/Cl- cotransporter and reducing sodium reabsorption, which leads to increased excretion of sodium and water, decreased plasma volume, and lower blood pressure[3]. Losartan is an angiotensin II receptor blocker (ARB) that selectively blocks the type 1 angiotensin II receptor (AT1) in vascular smooth muscle and adrenal gland tissue, preventing vasoconstriction and aldosterone-mediated effects, resulting in vasodilation and reduced blood pressure[5]. The combination offers additive or synergistic antihypertensive effects by targeting different mechanisms involved in blood pressure regulation. This combination may be used when monotherapy does not achieve adequate control of hypertension[6]. The indapamide + losartan combination is not widely available as a single branded product but may be prescribed as separate tablets taken together. It has demonstrated efficacy for lowering blood pressure in patients with hypertension uncontrolled by standard doses of monotherapy[6]. No specific developer or manufacturer for a fixed-dose product could be identified from current sources.

02

Targets

AGTR1 (Angiotensin II Type-1 receptor)SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on indapamide + losartan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on indapamide + losartan.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call